Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v1-EN
Language English English
Date Updated 2023-04-01 2022-10-12
Drug Identification Number 00382841 00382841
Brand name RIVOTRIL RIVOTRIL
Common or Proper name CLONAZEPAM CLONAZEPAM
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients CLONAZEPAM CLONAZEPAM
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size Bottles of 100 tablets Bottles of 100 tablets
ATC code N03AE N03AE
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-10-31 2022-10-31
Actual start date
Estimated end date 2023-03-31 2022-11-30
Actual end date 2023-03-31
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments